Overview


According to FutureWise analysis the market for Anticoccidial Drug is expected to register a CAGR of 4.30% from 2023-2031.

Coccidiosis, a parasitic disease in the intestinal tract of animals due to coccidian protozoa, is called "Coccidiosis". Coccidiosis spreads to other animals through contact with infected feces and ingestion of infected tissues. Diarrhea is the main symptom. In severe cases, it can become bloody. Coccidia is usually not a serious illness in animals. However, it can cause severe symptoms or even death in young and immunocompromised patients. Although coccidia can affect a variety of animals including livestock and birds, it is more common in certain species. Toxoplasma gondii, which causes toxoplasmosis, is a well-known exception. Coccidia can be first encountered by humans when they come in contact with a sick animal, such as a cat, dog, or bird. T. gondii is the only other infectious organism that can cause intestinal coccidiosis. Isospora species are only capable of infecting one species. I. canis and I. ohioensis are the most common species that infect dogs. I. burrowsi and I. neorivolta are also among them. I. felis, I. rivolta are two species that can infect cats. Diarrhea is the most common symptom. The most commonly used treatment is sulfonamides. Genus Eimeria can affect birds, poultry, and mammals like cattle and rabbits. E. tenella and E. Brunetti are the most common species. Sulfonamides work well. C. parvum, and C.muris are two of the cryptosporidiosis-causing species in Genus Cryptosporidium.

Most commonly, the disease affects cattle, but their feces could be an infection source for humans and other mammals. Recent human genetic tests have revealed that Cryptosporidium hominis is a pathogen-specific to humans. Most people with AIDS are immunocompromised, including dogs with canine distemper and cats with feline leukemia. Ingestion of cysts in the tissues of rodents and grazing animals can transmit genus Hammondia. Cats and dogs are the primary hosts. Dogs can be infected by H. heydorni, while cats can be infected by H. hammondi or H. pardalis. Symptoms rarely occur. Coccidian infections can be treated with most medications in the sulfonamide family. The major drivers of global anticoccidial drug market growth are the increased prophylactic use of anticoccidial medications and the increased demand for meat proteins. Global anticoccidial drug market growth is also supported by less stringent regulations and higher government spending on companion animals. The global anticoccidial drug market has tremendous potential for growth due to food safety issues and rising meat prices in different parts.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Anticoccidial Drug Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Anticoccidial Drug Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Zoetis
  • Bayer AG
  • Novartis AG
  • Bvirbac S.A.
  • HIPRA
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virabc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Class

  • Ionophores
  • Antibiotic
  • Sulphonamides
  • Amprolium
  • Others

By Animal Type

  • Livestock
    • Cattle
    • Poultry
    • Others
  • Companion Animal

By Distribution Channel

  • Veterinary Hospitals
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anticoccidial Drug Market By Drug Class, By Animal Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anticoccidial Drug Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anticoccidial Drug Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anticoccidial Drug Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anticoccidial Drug Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Ionophores
        2. Antibiotic
        3. Sulphonamides
        4. Amprolium
        5. Others

  • 8.   Anticoccidial Drug Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Livestock
         1.1. Cattle
         1.2. Poultry
         1.3. Others
        2. Companion Animal

  • 9.   Anticoccidial Drug Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary Hospitals
        2. Retail Pharmacy
        3. Online Pharmacy

  • 10.   North America Anticoccidial Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anticoccidial Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anticoccidial Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anticoccidial Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Anticoccidial Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zoetis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bayer AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Novartis AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bvirbac S.A.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. HIPRA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Elanco
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Boehringer Ingelheim International GmbH
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Virabc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients